Canadian Agency for Drugs and Technologies in Health. (2016). Combination atypical antipsychotics in adolescents or adults with bipolar disorder with psychotic features: A review of clinical and cost-effectiveness and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health.
Chicago Style CitationCanadian Agency for Drugs and Technologies in Health. Combination Atypical Antipsychotics in Adolescents or Adults With Bipolar Disorder With Psychotic Features: A Review of Clinical and Cost-effectiveness and Guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2016.
MLA CitationCanadian Agency for Drugs and Technologies in Health. Combination Atypical Antipsychotics in Adolescents or Adults With Bipolar Disorder With Psychotic Features: A Review of Clinical and Cost-effectiveness and Guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2016.